SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
4.150
+0.010 (0.24%)
Dec 30, 2024, 4:00 PM EST - Market closed
SAB Biotherapeutics Employees
SAB Biotherapeutics had 57 employees as of December 31, 2023. The number of employees increased by 1 or 1.79% compared to the previous year.
Employees
57
Change (1Y)
1
Growth (1Y)
1.79%
Revenue / Employee
$26,539
Profits / Employee
-$799,428
Market Cap
38.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57 | 1 | 1.79% |
| Dec 31, 2022 | 56 | -83 | -59.71% |
| Dec 31, 2021 | 139 | 53 | 61.63% |
| Dec 31, 2020 | 86 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
SABS News
- 7 weeks ago - SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 3 months ago - SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 4 months ago - SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting - GlobeNewsWire
- 5 months ago - SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates - GlobeNewsWire
- 5 months ago - SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes - GlobeNewsWire
- 5 months ago - SAB BIO Appoints Lucy To as Chief Financial Officer - GlobeNewsWire
- 6 months ago - SAb Biotherapeutics Rebrands as SAB BIO - GlobeNewsWire
- 6 months ago - SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions - GlobeNewsWire